Volition and vpg launch nu.q® vet cancer test in uk & ireland

Henderson, nev. , nov. 6, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, and veterinary pathology group (vpg), a leading high quality diagnostic laboratory, have joined forces to launch the nu.q® vet cancer test to veterinary practices in the uk and ireland.
VNRX Ratings Summary
VNRX Quant Ranking